Novo Nordisk (NVO) increased valuation gap with Eli Lilly (LLY) after its Phase 3 data for next-gen weight loss drug ...

Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...

Recent health news highlights include a landmark ruling by the Inter-American Court of Human Rights concerning abortion ...

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

Novo Nordisk's Attempt to Overtake Rival Eli Lilly in the Booming Obesity Medicine Market Fails. This Led to the Company's ...

U.S. stocks roared back on Friday to nearly halve their losses from what was tracking to be one of the market’s worst weeks ...

Zepbound, Eli Lilly's weight-loss treatment, received FDA approval for obstructive sleep apnea, benefiting a vast patient ...

As the festive season approaches, experts have a warning for those taking prescription GLP-1 receptor agonist drugs.

The Senate’s approval came shortly after the shutdown deadline. President Biden was expected to sign the bill, and preparations to close government agencies were called off. Trump Wanted ...

Can Canada avoid Trump tariffs? Likely some, but not all: ex-envoy Can Canada avoid Trump tariffs? Likely some, but not all: ex-envoy Canada's former ambassador to the United States says he’s ...